U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07554157) titled 'Development of a Pan-Cancer Screening Model Based on Blood Biomarkers' on April 14.
Brief Summary: This study aims to develop a pan-cancer screening model using routine blood biomarkers (including complete blood count, biochemical tests, coagulation panel, and tumor markers). The study is retrospective, collecting data from approximately 10,000,000 cancer patients diagnosed at multiple centers in China between January 2006 and September 2025. All patients have confirmed pathological diagnosis and complete blood test records. A Mixture of Experts (MoE) machine learning model will be built to predict the presence of various cancers (...